Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,025,334,063.23
- Feb. 18, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 18, 2025 | EVP | 244 | $455.06 | Sell | $111,034.64 | |
| Feb. 11, 2025 | EVP | 310 | $459.83 | Sell | $142,547.30 | |
| Nov. 15, 2024 | EVP | 15 | $478.56 | Sell | $7,178.40 | |
| Aug. 30, 2024 | Director | 646 | $500.00 | Sell | $323,000.00 | |
| Aug. 30, 2024 | Chairman | 3,784 | $499.00 | Sell | $1,888,216.00 | |
| Aug. 7, 2024 | CMO | 2,280 | $476.75 | Sell | $1,086,990.00 | |
| Aug. 1, 2024 | Director | 5,295 | $508.00 | Sell | $2,689,860.00 | |
| July 30, 2024 | Insider | 15,202 | $505.00 | Buy | $7,677,010.00 | |
| July 24, 2024 | CMO | 2,280 | $488.46 | Sell | $1,113,688.80 | |
| July 22, 2024 | CEO | 15,202 | $497.00 | Sell | $7,555,394.00 | |
| July 10, 2024 | CMO | 2,280 | $487.34 | Sell | $1,111,135.20 | |
| June 26, 2024 | CMO | 2,280 | $471.72 | Sell | $1,075,521.60 | |
| June 12, 2024 | CMO | 2,280 | $478.00 | Sell | $1,089,840.00 | |
| June 12, 2024 | EVP | 7,288 | $478.00 | Sell | $3,483,664.00 | |
| May 30, 2024 | EVP | 2,350 | $439.11 | Sell | $1,031,908.50 | |
| May 29, 2024 | CMO | 2,280 | $445.56 | Sell | $1,015,876.80 | |
| May 28, 2024 | CFO | 3,250 | $454.79 | Sell | $1,478,067.50 | |
| May 24, 2024 | CEO | 1,565 | $457.00 | Sell | $715,205.00 | |
| May 22, 2024 | Director | 7,073 | $448.00 | Sell | $3,168,704.00 | |
| Feb. 26, 2024 | EVP | 354 | $425.70 | Sell | $150,697.80 | |
| Feb. 20, 2024 | EVP | 480 | $420.79 | Sell | $201,979.20 | |
| Feb. 12, 2024 | EVP | 3,222 | $420.24 | Sell | $1,354,013.28 | |
| Feb. 12, 2024 | Chairman | 2,656 | $419.51 | Sell | $1,114,218.56 | |
| Feb. 12, 2024 | COO | 4,295 | $420.24 | Sell | $1,804,930.80 | |
| Feb. 12, 2024 | CAO | 1,374 | $420.24 | Sell | $577,409.76 | |
| Jan. 8, 2024 | Chairman | 6,648 | $419.07 | Sell | $2,785,977.36 | |
| Nov. 6, 2023 | Director | 11,250 | $385.00 | Sell | $4,331,250.00 | |
| Oct. 31, 2023 | CMO | 5,651 | $355.92 | Sell | $2,011,303.92 | |
| Oct. 17, 2023 | Director | 243 | $375.00 | Sell | $91,125.00 | |
| Oct. 17, 2023 | CMO | 5,651 | $373.25 | Sell | $2,109,235.75 | |
| Oct. 16, 2023 | Chairman | 12,962 | $374.00 | Sell | $4,847,788.00 | |
| Oct. 6, 2023 | Director | 242 | $360.00 | Sell | $87,120.00 | |
| Oct. 3, 2023 | CMO | 5,651 | $345.28 | Sell | $1,951,177.28 | |
| Oct. 2, 2023 | EVP | 610 | $346.76 | Sell | $211,523.60 | |
| Sept. 19, 2023 | CMO | 5,651 | $351.00 | Sell | $1,983,501.00 | |
| Aug. 23, 2023 | EVP | 2,500 | $355.00 | Sell | $887,500.00 | |
| Aug. 9, 2023 | Director | 242 | $345.51 | Sell | $83,613.42 | |
| Aug. 9, 2023 | EVP | 63 | $345.51 | Sell | $21,767.13 | |
| July 17, 2023 | CEO | 7,828 | $355.00 | Sell | $2,778,940.00 | |
| July 17, 2023 | Director | 11,250 | $356.75 | Sell | $4,013,437.50 | |
| June 15, 2023 | COO | 8,603 | $349.00 | Sell | $3,002,447.00 | |
| May 30, 2023 | COO | 82 | $329.82 | Sell | $27,045.24 | |
| May 30, 2023 | CAO | 289 | $329.82 | Sell | $95,317.98 | |
| May 8, 2023 | Chairman | 1,125 | $349.00 | Sell | $392,625.00 | |
| May 8, 2023 | EVP | 2,850 | $350.00 | Sell | $997,500.00 | |
| May 5, 2023 | Chairman | 879 | $349.56 | Sell | $307,263.24 | |
| May 5, 2023 | EVP | 422 | $350.03 | Sell | $147,712.66 | |
| May 2, 2023 | Director | 580 | $348.28 | Sell | $202,002.40 | |
| May 2, 2023 | Chairman | 6,450 | $349.89 | Sell | $2,256,790.50 | |
| May 2, 2023 | EVP | 1,622 | $350.66 | Sell | $568,770.52 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Ourania Tatsis, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Edward Morrow Atkinson III, Sangeeta N. Bhatia, Jonathan Biller, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Ian F. Smith, William D Young, Jeffrey M. Leiden, Lloyd Carney, and Kenneth Horton
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on Feb. 18, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.